CellaVision AB (publ) (CEVI.ST)

SEK 152.6

(-0.52%)

Long Term Debt Summary of CellaVision AB (publ)

  • CellaVision AB (publ)'s latest annual long term debt in 2023 was 28.66 Million SEK , down -52.51% from previous year.
  • CellaVision AB (publ)'s latest quarterly long term debt in 2024 Q2 was 21.31 Million SEK , down -16.39% from previous quarter.
  • CellaVision AB (publ) reported annual long term debt of 60.36 Million SEK in 2022, down -37.02% from previous year.
  • CellaVision AB (publ) reported annual long term debt of 95.84 Million SEK in 2021, up 10.29% from previous year.
  • CellaVision AB (publ) reported quarterly long term debt of 14.97 Million SEK for 2024 Q3, down -29.73% from previous quarter.
  • CellaVision AB (publ) reported quarterly long term debt of 25.49 Million SEK for 2024 Q1, down -11.06% from previous quarter.

Annual Long Term Debt Chart of CellaVision AB (publ) (2023 - 2007)

Historical Annual Long Term Debt of CellaVision AB (publ) (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 28.66 Million SEK -52.51%
2022 60.36 Million SEK -37.02%
2021 95.84 Million SEK 10.29%
2020 86.9 Million SEK -29.3%
2019 122.92 Million SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%
2016 - SEK 0.0%
2015 - SEK 0.0%
2014 - SEK 0.0%
2013 - SEK 0.0%
2012 - SEK 0.0%
2011 - SEK 0.0%
2010 - SEK 0.0%
2009 - SEK 0.0%
2008 - SEK 0.0%
2007 - SEK 0.0%

Peer Long Term Debt Comparison of CellaVision AB (publ)

Name Long Term Debt Long Term Debt Difference
Acarix AB (publ) - SEK -Infinity%
ADDvise Group AB (publ) 1.45 Billion SEK 98.032%
ADDvise Group AB (publ) 1.45 Billion SEK 98.032%
Arcoma AB 1.92 Million SEK -1387.494%
Bactiguard Holding AB (publ) 42.3 Million SEK 32.246%
BICO Group AB (publ) 1.75 Billion SEK 98.367%
Boule Diagnostics AB (publ) 57.7 Million SEK 50.322%
Clinical Laserthermia Systems AB (publ) 223 Thousand SEK -12753.812%
Chordate Medical Holding AB (publ) - SEK -Infinity%
C-Rad AB (publ) 1.75 Million SEK -1535.14%
Duearity AB (publ) 2.94 Million SEK -874.966%
Dignitana AB (publ) 6.07 Million SEK -371.68%
Episurf Medical AB (publ) 2.3 Million SEK -1146.261%
Getinge AB (publ) 3.9 Billion SEK 99.266%
Scandinavian Real Heart AB (Publ) 6.35 Million SEK -351.194%
Iconovo AB (publ) 4.9 Million SEK -484.157%
Integrum AB (publ) 4.84 Million SEK -491.675%
Luxbright AB (publ) 206.02 Thousand SEK -13812.942%
Mentice AB (publ) 2.14 Million SEK -1236.94%
OssDsign AB (publ) 214 Thousand SEK -13294.393%
Paxman AB (publ) 2.53 Million SEK -1032.07%
Promimic AB (publ) - SEK -Infinity%
Qlife Holding AB (publ) 3 Million SEK -854.194%
SciBase Holding AB (publ) 4.17 Million SEK -585.906%
ScandiDos AB (publ) - SEK -Infinity%
Sectra AB (publ) 19.2 Million SEK -49.261%
Sedana Medical AB (publ) 1.01 Million SEK -2732.411%
Senzime AB (publ) 8.57 Million SEK -234.157%
SpectraCure AB (publ) 4.39 Million SEK -551.899%
Stille AB 38.06 Million SEK 24.699%
Vitrolife AB (publ) 1.87 Billion SEK 98.471%
Xvivo Perfusion AB (publ) 21.16 Million SEK -35.406%